Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief:

Khurshid Zaman  
Bentham Science Publishers
USA

Back

Open Access Articles

Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options open Access plus

Volume: 13   Issue: 2
Pp: 209-223
Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*
DOI:10.2174/1574892813666180115151554

Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied open Access plus

Volume: 13   Issue: 2
Pp: 201-208
Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi
DOI:10.2174/1574892813666180220110729

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins open Access plus

Volume: 13   Issue: 2
Pp: 184-200
Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*
DOI:10.2174/1574892812666171129141211

PARP Inhibitors in Epithelial Ovarian Cancer open Access plus

Volume: 13   Issue: 2
Pp: 145-158
Kristin N. Taylor and Ramez N. Eskander*
DOI:10.2174/1574892813666171204094822

Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation open Access plus

Volume: 13   Issue: 2
Pp: 133-144
Juan F. Santibanez* and Suncica Bjelica
DOI:10.2174/1574892813666180220105958

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy open Access plus

Volume: 13   Issue: 1
Pp: 86-105
Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
DOI:10.2174/1574892812666171108124218

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy open Access plus

Volume: 13   Issue: 1
Pp: 2-17
Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*
DOI:10.2174/1574892812666171030163804

Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage open Access plus

Volume: 13   Issue: 1
Pp: 18-39
So-Yeon Park, Ji-Young Kim, Youngsoo Jun and Jeong-Seok Nam*
DOI:10.2174/1574892812666171003150410

Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature open Access plus

Volume: 13  
Pp: 1-6
Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*
DOI:10.2174/1574892813666180528105023

Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency open Access plus

Volume: 13  
Pp: 1-4
A. E. Shchekotikhin*, Georgy Y. Nadysev, Alexander S. Tikhomirov and Lyubov G. Dezhenkova
DOI:10.2174/1574892813666180723150542

From a Better Understanding of the Mechanisms of Action of Histone Deacetylases Inhibitors to the Progress of the Treatment of Malignant Lymphomas and Plasma Cell Myeloma open Access plus

Volume: 12   Issue: 4
Pp: 283-295
Romeo G. Mihaila*
DOI:10.2174/1574892812666170920110054

Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens open Access plus

Volume: 12   Issue: 2
Pp: 136-147
Zsuzsanna Suba*
DOI:10.2174/1574892812666170227110842

Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery* open Access plus

Volume: 11   Issue: 3
Pp: 254-266
Zsuzsanna Suba
DOI:10.2174/1574892811666160415160211

Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells open Access plus

Volume: 11   Issue: 2
Pp: 215-227
Yanming Wang, Jun Ma, Xinyan Yan, Xiaoyu Chen, Lingling Si, Ying Liu, Jichun Han, Wenjin Hao and Qiusheng Zheng
DOI:10.2174/1573406412666160307151904

Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells open Access plus

Volume: 11   Issue: 2
Pp: 197-214
Diego De Miguel, Ana Gallego-Lleyda, José M. Ayuso, Aleksandra Pawlak, Blanca Conde, Ignacio Ochoa, Luis J. Fernández, Alberto Anel and Luis Martinez-Lostao
DOI:10.2174/1574892811666160229121544

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment open Access plus

Volume: 11   Issue: 2
Pp: 184-196
Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian Luo
DOI:10.2174/1574892811888160304113346

Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy open Access plus

Volume: 11   Issue: 2
Pp: 141-151
Xiao-Na Fang and Li-Wu Fu
DOI:10.2174/1574892811666160226150506

Cabozantinib in Thyroid Cancer open Access plus

Volume: 10   Issue: 3
Pp: 259-269
Poupak Fallahi, Silvia M. Ferrari, Flavia Di Bari, Gabriele Materazzi, Salvatore Benvenga, Paolo Miccoli and Alessandro Antonelli
DOI:10.2174/1574892810666150708110816

Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women open Access plus

Volume: 8   Issue: 2
Pp: 154-167
Zsuzsanna Suba
DOI:10.2174/1574892811308020004

Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion open Access plus

Volume: 6   Issue: 3
Pp: 311-323
Sarah Shirley, Alexandre Morizot and Olivier Micheau
DOI:10.2174/157489211796957757